Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-038965)

Filing Details

Accession Number:: 0001209191-20-038965
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-25 17:48:49
Reporting Period:: 2020-06-23

Accepted Time:: 2020-06-25 17:48:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1538927	Forma Therapeutics Holdings Inc.	FMTX	Biological Products, (No Disgnostic Substances) (2836)	371657129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787092	L.p. I (Cayman) Investors Master Innovation Biomedical Wellington	Wellington Alternative Investments Llc 280 Congress Street Boston MA 02210		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-23	1,252,913	$0.00	1,252,913	No	4	C	Direct
Common Stock	Acquisiton	2020-06-23	1,000,000	$20.00	2,252,913	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Convertible Preferred Stock	Disposition	2020-06-23	5,359,344	$0.00	1,252,913	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

On June 23, 2020, the Series D Convertible Preferred Stock automatically converted into common stock on a 4.2775-for-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.